AstraZeneca in $560 m deal for respiratory firm
British drugmaker AstraZeneca PLC says it is to acquire Pearl Therapeutics Inc., a Redwood-City, California-based company involved in therapies for asthma and chronic obstructive pulmonary disease for at least $560 million.
Join the discussion below, or Read more at Seattle Times.
Since: Apr 13
#1 Jun 10, 2013
This sounds promising.
Add your comments below
|Bristol Palin says abstinence best path for teens (May '09)||Wed||Robby Rob||2,650|
|Myriad Genetics Announces an Assay that Identif...||Nov 24||Purplemouse2||2|
|Pfizer, Allergan in deal talks to create drug g... (Oct '15)||Nov 18||Fubar||5|
|Emotiv Insight, A Wireless Headset Designed to ...||Nov 13||InteraxonMuse8753...||1|
|RPT-Trump presidency could prove a salve for ph...||Nov 12||Philosophic||2|
|States With the Worst Sex Education||Nov 5||PubertatHvordanIk...||2|
|Seattle Genetics Demonstrates Commitment to Imp...||Oct '16||Rockstar||2|
Find what you want!
Search Biotech Forum Now
Copyright © 2016 Topix LLC